Calcineurin Inhibitors: all 995 studies that test it
Page 7 of 10. Open to participants first (83), then studies with results posted, then the rest; newest registration first within each.
- An Efficacy and Safety Study of Tacrolimus Ointment in Adult Participants With Atopic DermatitisCompletedNCT01828879Phase 4
- Myfortic in High MELD Liver TransplantationWithdrawnNCT01807767Not applicable
- Prograf-Advagraf Cross Over Conversion StudyCompletedNCT01797341Phase 3
- Tacrolimus/Methotrexate Versus Cyclosporine/Methotrexate for Prophylaxis of Graft Versus Host DiseaseCompletedNCT01788501Phase 2/3
- An Efficacy and Safety Study of Tacrolimus Ointment in Pediatric Participants With Atopic DermatitisCompletedNCT01782729Phase 4
- A Study to Assess the Efficacy and Safety of ASKP1240 in de Novo Kidney Transplant RecipientsCompletedNCT01780844Phase 2
- Study of Cyclosporine Ophthalmic Soution Group and Cyclosporine Ophthalmic Suspension GroupCompletedNCT01768312Phase 3
- the Effects and Safety of Idarubicin-strengthened Pretreatment Program and Conventional Busulfan Cyclophosphamide Pretreatment Program on High-risk Acute Myeloid Leukemia PatientStatus unknownNCT01766375Phase 3
- A Study to Evaluate the Effect of Tacrolimus and Corticosteroid Combination Therapy in Patients With Minimal Change Nephrotic SyndromeCompletedNCT01763580Phase 4
- The Insulin Independence Trial (IIT) Evaluating the Safety and Efficacy of Oral Cyclosporine and Oral Lansoprazole for Insulin Independence Among Patients With Existing Type 1 DiabetesWithdrawnNCT01762657Phase 3
- The Insulin Independence Trial (IIT) Evaluating the Safety and Efficacy of Oral Cyclosporine and Oral Omeprazole for Insulin Independence Among Recent Onset Type 1 Diabetes PatientsWithdrawnNCT01762644Phase 3
- Safety and Efficacy of Levamisole Combined With Cyclosporine A in Patients With Subclinical Paroxysmal Nocturnal Hemoglobinuria and PNH in the Setting of Another Bone Marrow Failure Syndromes(PNH-2013)Status unknownNCT01760096Phase 2
- Efficacy and Safety Study of Tacrobell to Treat Rheumatoid ArthritisCompletedNCT01746680Phase 4
- Preventive Treatment of Tacrolimus Ointment in Children With Atopic DermatitisCompletedNCT01745159Phase 4
- Efficacy and Safety Study of a 4-Month Post-Renal Transplant Dose Reduction of Tacrolimus(ADEQUATE)Status unknownNCT01744470Phase 4
- A Single Center, Open-label, Randomized, Pilot Study to Evaluate the Safety and Efficacy of a Tacrolimus Modified Release, ADVAGRAF®, Versus Tacrolimus Twice Daily, PROGRAF® in Stable Renal RecipientsCompletedNCT01742676Phase 4
- Study to Evaluate the Safety and Efficacy of Advagraf vs Prograf in Kidney Transplantation Patients 1 Month After the TransplantationCompletedNCT01742624Phase 4
- A Study to Assess the Effects of Cyclosporine on the Pharmacokinetics and Safety of Canagliflozin (JNJ-28431754) in Healthy VolunteersCompletedNCT01718652Phase 1
- Safety and Efficacy of the Early Introduction of Everolimus (Certican®) With Low Dose of Cyclosporine in de Novo Kidney Recipients After 1 Month of TransplantationCompletedNCT01706471Phase 4
- Evaluation Of Switching From Twice Daily Tacrolimus To Once Daily Formulation On Cardiovascular RiskCompletedNCT01702207Phase 4
- The Biomarker for Immunosuppressive Agents Metabolism in Chinese Renal Transplant RecipientsStatus unknownNCT01699360Phase 4
- Generic Tacrolimus in the Elderly - Prograf® vs Tacni®CompletedNCT01698541Phase 4
- Low Dose Cyclosporin A in Primary Sjögren SyndromeCompletedNCT01693393Phase 2
- A Study to Compare the Bioavailability and Pharmacokinetics of Cyclosporine After Intravenous Administration of NEUROSTAT®, a CREMOPHOR® EL-free Lipid Emulsion, and SANDIMMUNE® Injection (a Suspension of Cyclosporine in CREMOPHOR® EL) in Healthy VolunteersCompletedNCT01692834Phase 1
- A Comparison of the Effects of Extended Release Tacrolimus (Advagraf®) vs. Immediate Release Tacrolimus (Prograf®) on Kidney Function in Healthy Male VolunteersCompletedNCT01681134Phase 1
- Radiation- and Alkylator-free Bone Marrow Transplantation Regimen for Patients With Dyskeratosis CongenitaActive, not recruitingNCT01659606Phase 2
- CYCLosporinE A in Reperfused Acute Myocardial InfarctionCompletedNCT01650662Phase 3
- Safety and Efficacy of Levamisole Combined With Cyclosporine A in Patients With Classic Paroxysmal Nocturnal HemoglobinuriaStatus unknownNCT01642979Phase 2
- Effect of Different Therapeutic Strategies on Regulatory T Cells in Kidney TransplantationCompletedNCT01640743Not applicable
- A Study to Compare How the Body Absorbs and Processes Two Different Formulations of the Anti-rejection Medication Tacrolimus (Advagraf® or Prograf®) in Children Receiving an Organ Transplant, and How Safe and Effective They Are Over a Longer Period of TimeCompletedNCT01614665Phase 2
- A Clinical Trial to Assess the Efficacy and Safety of the Conversion to EverolimusStatus unknownNCT01608412Phase 4
- Cyclosporine A in Cardiac ArrestCompletedNCT01595958Phase 3
- Proactive Treatment of Tacrolimus Ointment for Adult Facial Seborrheic DermatitisCompletedNCT01591070Phase 4
- TOP-Study (Tacrolimus Organ Perfusion): Treatment of Ischemia Reperfusion Injury in Marginal Organs With an ex Vivo Tacrolimus PerfusionTerminatedNCT01564095Phase 2/3
- A Study Evaluating the Safety and Efficacy of QGE031 in Atopic Dermatitis PatientsCompletedNCT01552629Phase 2
- Tacrolimus Ointment in Oral Lichen PlanusTerminatedNCT01544842Not applicable
- Drug Interaction Study of Isavuconazole and TacrolimusCompletedNCT01535547Phase 1
- A Randomized Clinical Trial of the Effect of Pimecrolimus Cream 1% Compared With Topical Corticosteroid in Treatment of Erosive Oral Lichen PlanusStatus unknownNCT01524744Phase 2
- A Drug-Drug Interaction Study Between Danoprevir/Low-Dose Ritonavir and Cyclosporine in Healthy VolunteersCompletedNCT01514968Phase 1
- A Study is to Assess Efficacy and Safety of Tacrolimus in Active Rheumatoid Arthritis Patients Who Showed Unsuccessful Response to Existing Disease Modifying Antirheumatic Drugs (DMARDs)CompletedNCT01511003Phase 4
- Study to Assess Effect of Cyclosporine on the Blood Levels of TicagrelorCompletedNCT01504906Phase 1
- Drug Interaction Study of Isavuconazole and CyclosporineCompletedNCT01494597Phase 1
- Kidney Allograft Dysfunction Without Reversible CausesWithdrawnNCT01492894Phase 4
- Efficacy of 0.05% Cyclosporin Eye Drop in Stevens Johnson Syndrome Patient With Chronic Dry EyeCompletedNCT01488396Phase 4
- Sirolimus/Tacrolimus Combination After HLA Matched Related Peripheral Blood Stem Cell TransplantsTerminatedNCT01488253Phase 2
- A Study in Healthy Participants Investigating the Effect of TMC435 on the Pharmacokinetics of Immunosuppressants Cyclosporine and TacrolimusCompletedNCT01479881Phase 1
- The Efficacy and Safety of Tacrolimus in Treated Refractory Focal Segmental GlomerulosclerosisTerminatedNCT01451489Not applicable
- AADAPT - Analysis of Advagraf Dose Adaptation Post TransplantationCompletedNCT01435291Phase 4
- Pharmacokinetic Interaction Study to Assess the Effect of ASP015K on Tacrolimus in Healthy VolunteersCompletedNCT01430065Phase 1
- Tacrolimus Versus Cyclosporine for Immunosuppression After Lung TransplantationCompletedNCT01429844Phase 3
- Dasatinib and Cyclosporine in Treating Patients With Chronic Myelogenous Leukemia Refractory or Intolerant to Imatinib MesylateTerminatedNCT01426334Phase 1
- Rectal Tacrolimus in the Treatment of Resistant Ulcerative ProctitisCompletedNCT01418131Phase 4
- Advagraf/Prograf Conversion TrialCompletedNCT01410162Phase 4
- Clinical Trial of 0.0003% Calcitriol, 0.1% Tacrolimus, and Petrolatum for the Treatment of Pityriasis AlbaCompletedNCT01388517Phase 4
- A Paediatric, Open, Follow up Study With Modigraf Examining Safety and Efficacy in de Novo Allograft RecipientsTerminatedNCT01371344Phase 4
- A Study to Determine Pharmacokinetics of Children Receiving Modigraf (Tacrolimus Granules) Following Solid Organ TransplantationCompletedNCT01371331Phase 4
- Single Dose Study Of The Effect Of Cyclosporine On The Pharmacokinetics Of PF-04991532 In Health VolunteersCompletedNCT01370343Phase 1
- A Study to Compare the Efficacy and Safety of Tacrolimus Capsules With Leflunomide Tablets in Lupus Nephritis PatientsTerminatedNCT01342016Phase 3
- A Study to Assess the Pharmacokinetics, Safety and Efficacy of Advagraf and Prograf in de Novo Liver TransplantationCompletedNCT01339468Phase 4
- Comparison of Medication Adherence Between Once and Twice Daily Tacrolimus in Stable Renal Transplant RecipientsCompletedNCT01334333Phase 4
- Comparison of Efficacy and Safety of 0.1% Tacrolimus and 0.1% Mometasone Furoate for Adult VitiligoStatus unknownNCT01333410Phase 4
- Study to Compare the Pharmacokinetics of Tacrolimus in Adult Transplant Recipients Treated With Advagraf® or Prograf®CompletedNCT01332201Phase 2
- Efficacy and Safety of Tacrolimus Sustained-release Capsules in Induction Treatment in Refractory Lupus NephritisCompletedNCT01328834Phase 3
- A Study to Compare the Efficacy and Safety of Tacrolimus Capsules in Patient With Myasthenia GravisCompletedNCT01325571Phase 3
- A Study to Evaluate the Efficacy and Safety of Tacrolimus With Steroid in Korean Lupus Nephritis PatientsTerminatedNCT01316133Phase 4
- De Novo Everolimus-based Therapy for Renal Transplantation Using Rituximab InductionTerminatedNCT01312064Phase 4
- The Efficacy and Tolerance of Tacrolimus Sustained-release Capsules on Refractory Nephrotic Syndrome (RNS)CompletedNCT01309477Phase 3
- A Study Looking at Diabetes in Kidney Transplant Recipients Receiving Immunosuppressive Regimen With or Without SteroidsCompletedNCT01304836Phase 4
- Clinical Trial Treatment in Lupus NephritisWithdrawnNCT01299922Phase 3
- Study to Compare the Pharmacokinetics of Tacrolimus in Stable Pediatric Allograft Recipients Converted From Prograf® to Advagraf®CompletedNCT01294020Phase 2
- Efficacy and Safety of Tacrolimus Sustained-release Capsules in Induction Phase Treatment in Lupus NephritisWithdrawnNCT01288664Phase 3
- Study of Anti-r-HuEpo Associated Pure Red Cell Aplasia (PRCA) TreatmentTerminatedNCT01288131Phase 3
- Improving Secretion of Insulin in New Onset Diabetes After Renal TransplantationTerminatedNCT01268995Phase 2
- Topical Tacrolimus 0.1% Ointment For Treatment Of Cutaneous Crohn's DiseaseCompletedNCT01233570Phase 2
- Ciclosporin Versus Alitretinoin for Severe Atopic Hand Dermatitis.TerminatedNCT01231854Phase 4
- A Study to Evaluate the Efficacy of Tacrolimus in Rheumatoid Arthritis Patients Shown Unsuccessful Response to MethotrexateCompletedNCT01224418Phase 4
- Study to Evaluate the Efficacy of Tacrolimus in Rheumatoid Arthritis Patients Shown Unsuccessful Response to MethotrexateCompletedNCT01224041Phase 4
- A Study to Evaluate the Efficacy and Safety of Tacrolimus in Korean Nephropathy PatientsCompletedNCT01224028Phase 2
- Topical Cyclosporine for Vernal Keratoconjunctivitis (VKC) in RwandaCompletedNCT01211327Phase 4
- Tacrolimus Versus Cyclophosphamide as Treatment for Lupus NephritisCompletedNCT01207297Phase 1
- A Study to Evaluate the Drug Interaction of ASP015K and TacrolimusCompletedNCT01190670Phase 1
- Pimecrolimus Cream 1% (Elidel®) and Medicated Device Cream (EletoneTM) in the Treatment and Maintenance of Atopic Dermatitis.CompletedNCT01177566Phase 4
- Infusion of Off-the-Shelf Expanded Cord Blood Cells to Augment Cord Blood Transplant in Patients With Hematologic MalignanciesCompletedNCT01175785Phase 2
- Cyclosporine-A Versus Prednisolone for Induction of Remission in Auto-immune HepatitisCompletedNCT01170351Phase 3
- Drug Interaction Between Colchicine and Calcineurin Inhibitors in Renal Graft RecipientsCompletedNCT01160276Phase 1
- Bioavailability Study of Tacrolimus Capsules, 5 mg of Dr. Reddys's Laboratories Limited Under Non-Fasting ConditionsCompletedNCT01132027Phase 1
- Bioavailability Study of Tacrolimus Capsules, 5 mg of Dr. Reddy's Under Fasting ConditionsCompletedNCT01131988Phase 1
- Safety and Efficacy in LPL-Deficient Subjects of AMT-011, an Adeno-Associated Viral Vector Expressing Human Lipoprotein Lipase [S447X]Status unknownNCT01109498Phase 2/3
- Insulin Secretion and AdvagrafCompletedNCT01092806Phase 4
- Hematopoietic Stem Cell Transplantation for Malignant Infantile OsteopetrosisStatus unknownNCT01087398Phase 2/3
- Therapeutic Effect of Tacrolimus in Combination With Low Dose Corticosteroid in Adult Patient With Minimal Change Nephritic SyndromeCompletedNCT01084980Phase 2/3
- Bioequivalence Study of Tacrolimus 5 mg Capsule Under Fed ConditionCompletedNCT01080534Not applicable
- Bioequivalence Study of Tacrolimus 5 mg Capsule Under Fasting ConditionCompletedNCT01080482Not applicable
- Bioequivalence Study of Tacrolimus 1 mg Capsule Under Fed ConditionCompletedNCT01080469Not applicable
- Bioequivalence Study of Tacrolimus 1 mg Capsule Under Fasting ConditionCompletedNCT01080456Not applicable
- Efficacy Study of FK-506 and Cyclosporine in Vernal Keratoconjunctivits (VKC)CompletedNCT01068054Phase 2/3
- Safety and Tolerability of LIM-0705 in Healthy Male SubjectsCompletedNCT01060475Phase 1
- Fludarabine Phosphate, Busulfan, and Anti-Thymocyte Globulin Followed By Donor Peripheral Blood Stem Cell Transplant, Tacrolimus, and Methotrexate in Treating Patients With Myeloid MalignanciesCompletedNCT01056614Phase 2
- Long-Term Study of Multi-target Therapy as Maintenance Treatment for Lupus NephritisCompletedNCT01056237Not applicable
- a Comparative Pharmacokinetic Study of Two Oral Formulations of Tacrolimus in Renal Allograft RecipientsCompletedNCT01055964Phase 3